Harvard Scientist: The Diet That Lowers Cholesterol Like Statins (Without Drugs) EP#416

Simon Hill – The Proof
Simon Hill – The ProofMay 5, 2026

Why It Matters

Demonstrating a food‑based approach that matches statin efficacy could transform cardiovascular prevention and open sizable market demand for plant‑protein and whole‑grain products.

Key Takeaways

  • Plant‑protein, whole‑grain diet lowers LDL cholesterol comparable to statins.
  • Low‑carb diets raise type‑2 diabetes risk, especially animal‑based.
  • High butter intake increases mortality; plant oils reduce it.
  • Study shows diet quality, not carbs alone, drives health outcomes.
  • Ongoing CHEAP trial will test this dietary pattern in 1,100 participants.

Summary

The video features a Harvard scientist outlining a dietary pattern that combines higher plant protein and whole‑grain intake, claiming it can lower LDL cholesterol to levels rivaling prescription statins. The discussion references recent epidemiological data and contrasts it with popular low‑carb, high‑protein regimens promoted by figures like Peter Attia and Gabrielle Lyon.

Key findings include a 31% higher risk of type‑2 diabetes among low‑carb eaters, rising to 44% when the diet is animal‑based and low in whole grains. Conversely, participants with the highest butter consumption faced a 15% increase in total mortality, while those consuming the most plant‑based oils experienced a 16% mortality reduction. The analysis emphasizes that diet quality—not merely macronutrient ratios—drives cardiovascular and metabolic outcomes.

The presenter cites specific study metrics, such as the 15% mortality rise linked to butter and the protective effect of plant oils, and highlights the upcoming CHEAP trial, a 1,100‑person study designed to rigorously test this plant‑protein, whole‑grain regimen. The trial’s acronym, though tongue‑in‑cheek, signals a serious effort to validate the observational findings.

If the CHEAP trial confirms these results, dietary guidelines could shift toward emphasizing plant protein and whole grains as a non‑pharmaceutical strategy for cholesterol management, reshaping food industry product development and creating new market opportunities for healthier oil and grain alternatives.

Original Description

Dr. Andrea Glenn — registered dietitian, nutrition epidemiologist, and Harvard T.H. Chan postdoctoral researcher — breaks down her landmark plant-to-animal protein ratio study (200,000 participants, 30 years of data) and the evidence behind the portfolio diet, a dietary pattern shown in randomised trials to lower LDL cholesterol by 28-30% — comparable to a low-dose statin. She also unpacks why the source of your low-carb macronutrients may matter more than the macros themselves, and what a large Harvard cohort study found when it compared butter intake to plant-based oils and total mortality over three decades.
Stream the full episode on YouTube: https://youtu.be/eGpwGzjZouw
Want to support the show?
The best way to support the show is to use the products and services offered by our sponsors. To check them out, and enjoy great savings, visit https://theproof.com/friends/.
• The Proof with Simon Hill - https://theproof.com/podcast/
• Book: The Proof is in the Plants - https://theproof.com/book/
• Plant-Based Ferments Guide - https://theproof.com/ferments/
• Two-week meal plan - https://theproof.com/mealplan/
• Use the products and services offered by our sponsors. To check them out, and enjoy great savings, visit theproof.com/friends.

Comments

Want to join the conversation?

Loading comments...